SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ET who wrote (42225)1/5/1999 10:24:00 AM
From: Knighty Tin  Read Replies (1) of 132070
 
ET, I have followed it into the toilet. <G> Shaman is one of my dirty dozen small biotech firms (which sometimes number 8 and sometimes as much as 20 <G>) and one which has been a huge disappointment. I thought it had huge promise, but the results of the last clinical testing makes me think it was one of my many duds in this area. No, I do not blame the women managers or too much PC hype about the rainforest and touchy feely crapola. The science sounded good and it doesn't look like it worked in this case. Unfortunately, this is a co. with a financial structure that really needed its first drug to work.

I am not selling at these levels. My car is working so I don't need cab fare. <G> And maybe I read the report wrongly, I hope.

BTW, I expect this in my biotech approach. I have always said that I expect half the cos. to go belly up, while the other half goes up 400-1000%. So, while other stocks have made me a ton of money, this is one where I think a fork may be stuck, because it looks done.

MB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext